Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation inCARD14-Reference-Cited by-同舟云学术

Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation inCARD14

Published:2014-08 Issue:2 Volume:171 Page:420-422
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Eytan O.¹²,Sarig O.¹,Sprecher E.¹²,van Steensel M.A.M.³⁴

Affiliation:

1. Department of Dermatology; Tel Aviv Sourasky Medical Center; Tel Aviv 642395 Israel

2. Department of Human Molecular Genetics & Biochemistry; Sackler Faculty of Medicine; Tel Aviv University; Ramat Aviv 69978 Israel

3. Department of Dermatology and GROW School for Oncology and Developmental Biology; Maastricht University Medical Centre; Maastricht 6200 The Netherlands

4. Department of Clinical Genetics; Maastricht University Medical Centre; Maastricht 6200 The Netherlands

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12952/fullpdf

Reference10 articles.

1. Familial pityriasis rubra pilaris;Vanderhooft;Arch Dermatol,1995

2. Familial pityriasis rubra pilaris is caused by mutations in CARD14;Fuchs-Telem;Am J Hum Genet,2012

3. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B;Bertin;J Biol Chem,2001

4. PSORS2 is due to mutations in CARD14;Jordan;Am J Hum Genet,2012

5. Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center;Eastham;JAMA Dermatol,2014

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory linear verrucous epidermal nevus should be genotyped to direct treatment and genetic counseling;Journal of the American Academy of Dermatology;2024-06

2. Severe atypical juvenile pityriasis rubra pilaris diagnosed in adulthood with a dramatic improvement with ustekinumab;Skin Health and Disease;2024-04-11

3. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD‐CC protein family;The FEBS Journal;2023-12-25

4. Biologics for inherited disorders of keratinisation: A systematic review;Australasian Journal of Dermatology;2023-12-21

5. Successful treatment of CARD14‐negative juvenile Pityriasis rubra pilaris with Ustekinumab;Journal of the European Academy of Dermatology and Venereology;2023-12-12